Extract from the Register of European Patents

EP About this file: EP1240325

EP1240325 - IL-17 AND IL-17R HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.08.2010
Database last updated on 01.04.2026
Most recent event   Tooltip23.09.2011Lapse of the patent in a contracting state
New state(s): TR
published on 26.10.2011  [2011/43]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2009/40]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco CA 94080-4990 / US
Former [2002/38]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / CHEN, Jian
121 York Drive
Princeton, NJ 08540 / US
02 / FILVAROFF, Ellen
538 18th Avenue
San Francisco, CA 94121 / US
03 / FONG, Sherman
19 Basinside Way
Alameda, CA 94502 / US
04 / GODDARD, Audrey
110 Congo Street
San Francisco, CA 94131 / US
05 / GODOWSKI, Paul, J.
2627 Easton Drive
Burlingame, CA 94010 / US
06 / GRIMALDI, Christopher, J.
1434 36th Avenue
San Francisco, CA 94122 / US
07 / GURNEY, Austin, L.
1 Debbie Lane
Belmont, CA 94002 / US
08 / LI, Hanzhong
538 18th Avenue
San Francisco, CA 94121 / US
09 / HILLAN, Kenneth, J.
64 Seward Street
San Francisco, CA 94114 / US
10 / TUMAS, Daniel
3 Rae Avenue
Orinda, CA 94563 / US
11 / VAN LOOKEREN, Menno
261 Molimo Drive
San Francisco, CA 94127 / US
12 / VANDLEN, Richard, L.
1015 Hayne Road
Hillsborough, CA 94010 / US
13 / WATANABE, Colin, K.
128 Corliss Drive
Moraga, CA 94556 / US
14 / WILLIAMS, P., Mickey
509 Alto Avenue
Half Moon Bay, CA 94019 / US
15 / WOOD, William, I.
35 Southdown Court
Hillsborough, CA 94010 / US
16 / YANSURA, Daniel, G.
330 Carmel Avenue
Pacifica, CA 94044 / US
 [2002/38]
Representative(s)Denison, Christopher Marcus, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2002/38]Denison, Christopher Marcus, et al
Mewburn Ellis York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date00989401.520.12.2000
[2002/38]
WO2000US34956
Priority number, dateUS19990172096P23.12.1999         Original published format: US 172096 P
WO1999US3127430.12.1999         Original published format: PCT/US99/31274
US20000175481P11.01.2000         Original published format: US 175481 P
WO2000US0434118.02.2000         Original published format: PCT/US00/04341
WO2000US0584102.03.2000         Original published format: PCT/US00/05841
US20000191007P21.03.2000         Original published format: US 191007 P
WO2000US0753221.03.2000         Original published format: PCT/US00/07532
WO2000US1526402.06.2000         Original published format: PCT/US00/15264
US20000213807P22.06.2000         Original published format: US 213807 P
US2000064484822.08.2000         Original published format: US 644848
WO2000US2332824.08.2000         Original published format: PCT/US00/23328
US20000242837P24.10.2000         Original published format: US 242837 P
WO2000US3087310.11.2000         Original published format: PCT/US00/30873
US20000253646P28.11.2000         Original published format: US 253646 P
WO2000US3267801.12.2000         Original published format: PCT/US00/32678
[2003/10]
Former [2002/38]US19990172096P23.12.1999
WO1999US3127430.12.1999
US20000175481P11.01.2000
WO2000US0434118.02.2000
WO2000US0584102.03.2000
US20000191007P21.03.2000
WO2000US0753221.03.2000
WO2000US1526402.06.2000
US20000213087P22.06.2000
US2000064484822.08.2000
WO2000US2332824.08.2000
US20000242837P24.10.2000
WO2000US3087310.11.2000
US20000253646P28.11.2000
WO2000US3267801.12.2000
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0146420
Date:28.06.2001
Language:EN
[2001/26]
Type: A2 Application without search report 
No.:EP1240325
Date:18.09.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 28.06.2001 takes the place of the publication of the European patent application.
[2002/38]
Type: B1 Patent specification 
No.:EP1240325
Date:30.09.2009
Language:EN
[2009/40]
Search report(s)International search report - published on:EP10.05.2002
ClassificationIPC:C12N15/12, C07K14/715, C07K14/54, C12N15/62, C07K16/24, C07K16/28, A61K31/70, A61K38/17, A61K38/20, A61K39/395, G01N33/566, G01N33/53
[2002/38]
CPC:
C07K14/54 (EP); A61P1/00 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/04 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/02 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P5/14 (EP); A61P7/00 (EP);
A61P7/02 (EP); A61P7/04 (EP); A61P7/06 (EP);
A61P9/00 (EP); C07K14/7155 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/38]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:IL-17 UND IL-17R HOMOLOGE POLYPEPTIDE UND DEREN THERAPEUTISCHE VERWENDUNGEN[2009/15]
English:IL-17 AND IL-17R HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF[2002/38]
French:POLYPEPTIDES HOMOLOGUES DE L'IL-17 ET DE L'IL-17R ET LEURS UTILISATIONS THERAPEUTIQUES[2009/15]
Former [2002/38]ZU IL-17 UND IL-17R HOMOLOGE POLYPEPTIDE UND DEREN THERAPEUTISCHE VERWENDUNGEN
Former [2002/38]POLYPEPTIDES HOMOLOGUES DE L'IL-17 ET LEURS UTILISATIONS THERAPEUTIQUES
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase07.06.2002National basic fee paid 
07.06.2002Designation fee(s) paid 
07.06.2002Examination fee paid 
Examination procedure11.06.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.06.2002Examination requested  [2002/38]
04.10.2004Despatch of a communication from the examining division (Time limit: M06)
14.04.2005Reply to a communication from the examining division
29.08.2006Despatch of a communication from the examining division (Time limit: M06)
08.03.2007Reply to a communication from the examining division
11.03.2008Despatch of a communication from the examining division (Time limit: M03)
21.05.2008Reply to a communication from the examining division
06.04.2009Communication of intention to grant the patent
12.08.2009Fee for grant paid
12.08.2009Fee for publishing/printing paid
Divisional application(s)EP07016899.2  / EP1897943
EP07016900.8  / EP1897944
EP07016901.6  / EP1897945
EP07016902.4  / EP1897946
EP07016903.2  / EP1897947
EP09009972.2  / EP2163625
EP10009490.3  / EP2290081
EP10009491.1  / EP2258848
Opposition(s)01.07.2010No opposition filed within time limit [2010/36]
Fees paidRenewal fee
12.12.2002Renewal fee patent year 03
12.12.2003Renewal fee patent year 04
14.12.2004Renewal fee patent year 05
15.12.2005Renewal fee patent year 06
13.12.2006Renewal fee patent year 07
12.12.2007Renewal fee patent year 08
15.12.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY30.09.2009
TR30.09.2009
LU20.12.2009
[2011/43]
Former [2011/21]CY30.09.2009
LU20.12.2009
Former [2010/35]CY30.09.2009
Former [2010/25]CY30.09.2009
Documents cited:Search[EL] WO0140465  (GENENTECH INC et al.) [EL] 1-32,41-58 * (L: Priority); pages 1-98; claims 1-36; sequences 17,18 *
 [EL] WO0116318  (GENENTECH INC et al.) [EL] 1-32,41-58 * (L: Priority); pages 1-98; claims 1-38; sequences 155,156 *
 [E] WO0208285  (AMGEN INC et al.) [E] 1-32,41-58 * example 1; claims 1-74; sequences 1,2 *
 [PX] WO0042188  (SCHERING CORP et al.) [PX] 1-32,41-58 * page 16; claims 1-20 *
 [E] WO0179288  (SCHERING CORP et al.) [E] 1-32,41-58 * pages 1-20; claims 1-14; sequences 1,2 *
 [E] WO0168705  (AMGEN INC et al.) [E] 1-32,41-58 * examples 7-13; claims 1-89; sequences 22,23 *
 [PX] WO0042187  (SCHERING CORP et al.) [PX] 1-32,41-58 * page 19; claims 1-20 *
 [A] WO9961617  (HUMAN GENOME SCIENCES INC et al.) [A] 1-32,41-58 * figure 6; claims 1-49 *
 [A] WO9960127  (GENENTECH INC et al.) [A] 1-32,41-58 * page 138 - page 139; figure 4; example 11; claims 1-42 *
 [T]   LEE JAMES ET AL: "IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 276, no. 2, 12 January 2001 (2001-01-12), pages 1660 - 1664, XP002196319, ISSN: 0021-9258 [T] 1-32,41-58 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M008289200
 [X]   DATABASE EMBL [online] 9 November 1999 (1999-11-09), GENOSCOPE: "Human chromosome 14 DNA sequence BAC C-2201G16 of library CalTech-D from chromosome 14 of Homo sapiens (Human)", XP002297072, Database accession no. AL132855 [X] 1 * the whole document *
 [X]   DATABASE EMBL [online] 4 July 1996 (1996-07-04), MARRA M ET AL: "mf68b10.r1 Soares mouse embryo NbME13.5 14.5 Mus musculus cDNA clone IMAGE: sequence.", XP002297073, Database accession no. W88186 [X] 1 * the whole document *
 [A]   YAO Z ET AL: "HUMAN IL-17: A NOVEL CYTOKINE DERIVED FROM T CELLS", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 155, no. 12, 15 December 1995 (1995-12-15), pages 5483 - 5486, XP000602481, ISSN: 0022-1767 [A] 1-32,41-58 * the whole document *
International search[A]   ROUVIER E ET AL: "CTLA-8, CLONED FROM A ACTIVATED T CELL, BEARING AU-RICH MESSENGER RNA INSTABILITY SEQUENCES, AND HOMOLOGOUS TO A HERPESVIRUS SAIMIRI GENE", JOURNAL OF IMMUNOLOGY,US,THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 150, no. 12, 15 June 1993 (1993-06-15), pages 5445 - 5456, XP002035505, ISSN: 0022-1767
 [PXL]   SHI ET AL: "A novel cytokine receptor-ligand pair: Identification, molecular characterization and in vivo immunomodulatory activty", JOURNAL OF BIOLOGICAL CHEMISTRY,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD,US, vol. 275, no. 25, 23 June 2000 (2000-06-23), pages 19167 - 19176, XP002161114, ISSN: 0021-9258

DOI:   http://dx.doi.org/10.1074/jbc.M910228199
 [PX]   H LI ET AL: "Cloning and characterization of the iL-17B and iL-17C, two members of the iL-17 cytokine family", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,NATIONAL ACADEMY OF SCIENCE. WASHINGTON,US, vol. 97, no. 2, 18 January 2000 (2000-01-18), pages 773 - 778, XP002139729, ISSN: 0027-8424 [PX] 1-20,24,33-35,41-44,49-51,55,56 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.97.2.773
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.